arrow
Back
C

Chelsea McKibbon

Cytel

3H-index
6Paper Count
20Citation Count
Published Papers 2
Publication Date
Real-world survival outcomes, treatment patterns, and impact of PD-L1 expression among patients with unresectable, stage III NSCLC treated with CRT → durvalumab in Canada: The RELEVANCE study
err2025-06-01
err0
errOAAI
errWheatley-Price, Paul; Navani, Vishal; Pabani, Aliyah; Routy, Bertrand; Snow, Stephanie; Denault, Marie-Helene; Kim, YongJin; Syed, Iqra; Devost, Natalie; Hui, Daphne; Qadeer, Rana A.; Arora, Paul; Velummailum, Russanthy; Springford, Aaron; McKibbon, Chelsea; Ho, Cheryl
errShare
errSave
Data Challenges for Externally Controlled Trials: Viewpoint
err2023-04-05
err5
errOAAI
errVelummailum, Russanthy Ruthiran; McKibbon, Chelsea; Brenner, Darren R.; Stringer, Elizabeth Ann; Ekstrom, Leeland; Dron, Louis
errShare
errSave